XML 151 R136.htm IDEA: XBRL DOCUMENT v3.6.0.2
Condensed Parent Company Financial Statements (Statements Of Cash Flows) (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 12 Months Ended
Jun. 30, 2016
Dec. 31, 2016
Sep. 30, 2016
Jun. 30, 2016
Mar. 31, 2016
Dec. 31, 2015
Sep. 30, 2015
Jun. 30, 2015
Mar. 31, 2015
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Operating Activities:                        
Net income   $ 54,608 $ 53,115 $ 50,041 $ 49,111 $ 35,512 $ 38,355 $ 43,831 $ 39,052 $ 206,875 $ 156,749 $ 151,398
Adjustments to reconcile net income to net cash provided by (used for) operating activities                        
Provision for credit losses   7,350 $ 9,571 $ 9,129 8,034 9,059 $ 8,322 $ 9,482 6,079 34,084 32,942 20,537
Losses on available-for-sale securities, net                   (7,645) (323) 504
Gain on early extinguishment of debt                   (3,588) 0 0
Depreciation and amortization                   53,148 41,010 37,792
Deferred income tax (benefit) expense                   6,676 23,054 4,125
Stock-based compensation expense                   9,303 9,656 7,754
Excess tax benefits from stock-based compensation arrangements                   (951) (744) (444)
Increase in other assets                   (43,614) (151,132) 72,479
Increase in other liabilities                   113,258 292 (38,902)
Net Cash Provided by Operating Activities                   309,081 38,222 206,368
Investing Activities:                        
Net cash paid for acquisitions, net                   (613,619) (15,428) 228,946
Net Cash Used for Investing Activities                   (2,492,665) (1,641,553) (1,837,592)
Financing Activities:                        
(Decrease) increase in subordinated notes, other borrowings and junior subordinated debt, net                   (3,405) 44,415 (59,384)
Proceeds from the issuance of subordinated notes, net                   0 0 139,090
Excess tax benefits from stock-based compensation arrangements                   951 744 444
Proceeds from the issuance of common stock, net $ 152,900                 152,911 0 0
Net proceeds from issuance of Series D Preferred Stock                   0 120,842 0
Issuance of common shares resulting from exercise of stock options, employee stock purchase plan and conversion of common stock warrants                   15,828 16,119 10,453
Dividends paid                   (38,568) (29,888) (24,933)
Common stock repurchases                   (616) (424) (549)
Net Cash Provided by Financing Activities                   2,177,834 1,648,419 1,598,067
Net (Decrease) Increase in Cash and Cash Equivalents                   (5,750) 45,088 (33,157)
Cash and Cash Equivalents at Beginning of Period         275,795       230,707 275,795 230,707 263,864
Cash and Cash Equivalents at End of Period   270,045       275,795       270,045 275,795 230,707
Reportable Legal Entities | Parent Company                        
Operating Activities:                        
Net income                   206,875 156,749 151,398
Adjustments to reconcile net income to net cash provided by (used for) operating activities                        
Provision for credit losses                   0 (96) 945
Losses on available-for-sale securities, net                   0 0 33
Gain on early extinguishment of debt                   (4,305) 0 0
Depreciation and amortization                   10,400 8,323 7,853
Deferred income tax (benefit) expense                   (601) (1,872) 2,753
Stock-based compensation expense                   3,762 3,354 2,654
Excess tax benefits from stock-based compensation arrangements                   (225) (278) (139)
Increase in other assets                   (319) (39,051) (4,473)
Increase in other liabilities                   9,618 21,840 7,114
Equity in undistributed net income of subsidiaries                   (197,861) (183,830) (111,622)
Net Cash Provided by Operating Activities                   27,344 (34,861) 56,516
Investing Activities:                        
Capital contributions to subsidiaries, net                   (118,575) (97,400) (105,244)
Net cash paid for acquisitions, net                   (61,308) (51,060) 0
Other investing activity, net                   (18,051) (24,908) (3,907)
Net Cash Used for Investing Activities                   (197,934) (173,368) (109,151)
Financing Activities:                        
(Decrease) increase in subordinated notes, other borrowings and junior subordinated debt, net                   (26,251) 66,888 (1,131)
Proceeds from the issuance of subordinated notes, net                   0 0 139,090
Excess tax benefits from stock-based compensation arrangements                   225 278 139
Proceeds from the issuance of common stock, net                   152,911 0 0
Net proceeds from issuance of Series D Preferred Stock                   0 120,842 0
Issuance of common shares resulting from exercise of stock options, employee stock purchase plan and conversion of common stock warrants                   15,828 16,119 10,453
Dividends paid                   (38,568) (29,888) (24,933)
Common stock repurchases                   (616) (424) (549)
Net Cash Provided by Financing Activities                   103,529 173,815 123,069
Net (Decrease) Increase in Cash and Cash Equivalents                   (67,061) (34,414) 70,434
Cash and Cash Equivalents at Beginning of Period         $ 116,889       $ 151,303 116,889 151,303 80,869
Cash and Cash Equivalents at End of Period   $ 49,828       $ 116,889       $ 49,828 $ 116,889 $ 151,303